Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0001430 (adenoma)
 21,222 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Intraductal papillary growth of mucin producing hypersecreting, columnar cells characterizes a group of rare pancreatic exocrine neoplasms which we propose to call intraductal papillary-mucinous tumors (IPMT). We analysed the histopathology of 26 IPMT in relation to gastro-enteropancreatic marker expression, genetic changes and biology. Four IPMT showing only mild dysplasia were considered to be adenomas. Nine tumours displayed moderate dysplasia and were regarded as borderline. Severe dysplasia-carcinoma in situ changes were found in 13 IPMT which were therefore classified as intraductal carcinomas. Six of these carcinomas were frankly invasive and two of these had lymph node metastases. The invasive component resembled mucinous non-cystic carcinoma in all but one tumour which showed a ductal invasion pattern. Immunohistochemically, an intestinal marker type was found in most carcinomas, while gastric type differentiation prevailed among adenomas or borderline tumours. K-ras mutations (seven at codon 12 and one at codon 13) were found in 31% of IPMT (2 adenomas, 1 borderline, 5 carcinomas). Nuclear p53 overexpression was detected in 31% of IPMT (6 carcinomas and 2 borderline IPMT) and correlated with p53 mutations (one at exon 8 and the other at exon 5) in two carcinomas. p53 abnormalities were unrelated to K-ras mutation. c-erbB-2 overexpression was observed in 65% of IPMT, with various grades of dysplasia. Twenty-two of 24 patients are alive and well after a mean post-operative follow-up of 41 months. Only two patients, both with invasive cancer at the time of surgery, died of tumour disease. It is concluded that pancreatic IPMT encompass neoplasms which, in general, have a favorable prognosis, but are heterogeneous in regard to grade of dysplasia and marker expression. Adenoma, borderline tumour, intraductal carcinoma and invasive carcinoma can be differentiated. p53 changes but not K-ras mutation or c-erbB-2 overexpression are related to the grade of malignancy. Most IPMT differ in histological structure, marker expression and behaviour from ductal adenocarcinoma.
 ...
PMID:Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients. 782 Mar

DF3(CA15-3) monoclonal antibody detects the 20 amino acid sequence of epithelial mucin. In normal cutaneous tissue DF3 antibody exhibits strong and constant positive reactivity with sebaceous and secretory segments of eccrine and apocrine sweat glands. All epidermal tumors are DF3 negative but poorly differentiated squamous cell carcinoma. Various adnexal tumors such as eccrine hidrocystoma, tubular apocrine adenoma, syringocystadenoma papilliferum, eccrine poroma, eccrine spiradenoma, clear cell hidradenoma, mixed cell tumor, eccrine porocarcinoma, extramammary Paget's disease and adenoid cystic carcinoma are DF3 positive, which indicates epithelial mucin production by these tumors.
 ...
PMID:DF3 (CA15-3) antibody as a marker of cutaneous adnexal tumors. 791 37

The expression of mucin MUC2 was investigated in normal colonic tissue, in colonic adenomas and in carcinomas of the mucinous and non-mucinous type. The latter were subdivided into carcinomas originating from the adenoma-carcinoma sequence (ACS) and de novo (DN) carcinomas. The expression was assayed by immunohistochemistry with the monoclonal anti-MUC2 antibody CCP58 and by mRNA semiquantitation. MUC2 protein epitope CCP58 was strongly expressed in 21% of normal colonic tissues, in 40% of villous and in 48% of tubular adenomas. Mucinous carcinomas exhibited strong expression in 72%, ACS carcinomas in 21% and DN adenocarcinomas in none of the tumors investigated. Compared with the adjacent non-malignant tissue (transitional mucosa), CCP58 epitope expression in the tumor was higher in 74% of mucinous carcinomas, but equal or lower in 69% of ACS carcinomas and in 100% of de novo carcinomas. The alterations of MUC2 expression detected by immunohistochemistry in adenocarcinomas were confirmed on mRNA level. These data indicate that the MUC2 expression pattern is different in the 3 carcinoma types investigated. MUC2 over-expression occurs in the adenomatous tissue. It is always maintained in mucinous carcinomas, but frequently decreased in non-mucinous ACS carcinomas. DN carcinomas are most frequently associated with decreased expression of MUC2.
 ...
PMID:Expression of MUC2-mucin in colorectal adenomas and carcinomas of different histological types. 792 33

Forty patients with pancreatic diseases (11 cancer, 1 islet cell tumor, 12 mucin-producing tumor, 1 teratoma, and 15 chronic pancreatitis) were studied in vivo with ERP and were also scanned with an intraductal ultrasound (IDUS) probe at a frequency of 30 MHz inserted into the main pancreatic duct. The usefulness of in vivo IDUS was evaluated by comparison of images with the ERP findings. IDUS was of diagnostic value in 18 of the 40 patients; it distinguished between 4 malignant and 6 benign causes of localized stenosis revealed by ERP, provided parenchymal information in 2 cases with only displacement revealed by ERP (1 islet cell tumor and 1 teratoma), and determined the extent of tumor in 6 cases with main-duct-type mucin-producing tumor. Ten of 11 cancer, 4 of 12 mucin-producing tumor, 1 islet cell tumor, and 11 of 15 chronic pancreatitis (previously scanned in vivo), and 2 islet cell tumor (not scanned in vivo), were resected and scanned in vitro. Fifteen normal pancreases from autopsy subjects were also scanned in vitro. The IDUS images were then compared with corresponding histopathological sections from the 15 normal pancreases and 28 post-operative pancreatic specimens. Differential diagnosis of the pancreatic diseases by echo patterns was possible in all cases except those with intraductal papillary adenocarcinoma and adenoma.
 ...
PMID:Differential diagnosis of pancreatic diseases with an intraductal ultrasound system. 801 24

A human colonic adenoma cell line PC/AA derived from a familial polyposis coli patient was passaged in culture to form an intermediate premalignant clonogenic variant AA/C1 and, upon treatment with differentiating and carcinogenic agents, a cell line AA/C1/SB10 which is tumourigenic in nude mice. These three mucin-secreting cell lines have been used as a model to study the changes in O-glycan biosynthesis during the progression to cancer. Several glycosyltransferases involved in the synthesis, elongation and termination of the common O-glycan core structures were found to decrease in the progression sequence towards adenocarcinoma. Higher activity of a number of enzymes was seen in the intermediate cell line. O-glycan biosynthesis in the original PC/AA cell line was closest to the normal human colonic phenotype, since all four common mucin O-glycan cores and their extended structures could be synthesized; core 3 beta 3-GlcNAc-transferase and alpha 6-sialytransferase acting on GalNAc-mucin were still detectable and core 2 beta 6-GlcNAc-transferase activity was accompanied by core 4 and I beta 6-GlcNAc-transferase activities. During progression towards adenocarcinoma, the expression of alpha 6-sialyltransferase, core 3 beta 3-GlcNAc-transferase, core 4 and I beta 6-GlcNAc-transferases were turned off. Using monoclonal antibodies, Tn antigen, sialyl-Tn antigen, O-acetyl-sialomucin and sialyl-Lea determinants were not detected in secreted or cellular mucin isolated from any of the cell lines. The exposure of MUC1 epitopes was seen in the malignant line, whereas sialyl-Lex determinants were found only in the premalignant PC/AA line. Sulfotransferase activities using core 1 substrate, Gal beta 1-3GalNAc alpha-benzyl, were high in PC/AA cells and progressively decreased upon development to adenocarcinoma, and this decrease correlated with mucin sulfation. In summary, the synthesis of less abundant, sialylated, fucosylated and extended, unbranched core 1 structures should be facilitated in the malignant cells. This is the first report of glycosyltransferase changes in human premalignant cells developing to tumourigenic cells. The data demonstrate that these cell lines are an excellent model to study the changes and regulation of mucin oligosaccharide biosynthesis during progression to cancer.
 ...
PMID:O-glycan biosynthesis in human colorectal adenoma cells during progression to cancer. 802 Apr 79

We performed a clinicopathologic analysis of 74 periampullary and duodenal adenomas from 30 patients with familial adenomatous polyposis to evaluate the growth pattern, mucin histochemical profile, and degree and significance of Paneth cell and endocrine cell differentiation in these lesions. A trend toward more numerous adenomas was seen in patients with the longest intervals since their previous colectomies. Adenomas were most often clustered in the periampullary region and were numerous (> 20) in 40% of patients. Periampullary and duodenal adenomas were morphologically similar; both exhibited the same size-villous shape-dysplasia relationship as sporadic and familial adenomatous polyposis-associated colonic adenomas. Adenomas showed a heterogenous pattern of mucin production (mixed small intestinal-large intestinal types), with a shift toward the colonic type (sulfomucin) in lesions that were larger, villous, or severely dysplastic. Ninety-two percent of adenomas showed Paneth cell differentiation (average n Paneth cells/high power field = 24.5), and 99% showed endocrine cell differentiation (average n endocrine cells/high power field = 64.4). In general, the proportion of these specialized cell types was inversely related to size, villous shape, and degree of epithelial dysplasia. These results suggest that periampullary and duodenal adenomas in familial adenomatous polyposis arise from the neoplastic transformation of an undifferentiated stem cell that retains its ability for multidirectional differentiation.
 ...
PMID:Duodenal adenomas in familial adenomatous polyposis: relation of cell differentiation and mucin histochemical features to growth pattern. 805 11

A total of 44 cases of pancreatic lesions, including hyperplasia (six) cases, adenoma (mucinous cystadenomas [eight] and intraductal papillary adenoma [eight]), noninvasive intraductal papillary tumors (five), and invasive ductal carcinomas (17) were investigated possibly to establish a diagnostic marker. We examined the type of mucin secreted and immunoreactivities of antibodies to ras-p21 and c-erB-2 oncogene products. A significant decrease in the amount of mucin was found in invasive lesions, and this was associated with a shift toward production of neutral mucins and especially sialomucins. Hyperplasia and adenoma, in contrast, demonstrated a predominance of neutral mucin. The sulfated mucins found in normal epithelium were only very weakly stained in any of the tumor types. Thirty-three percent of non-invasive intraductal papillary tumors and 88% of invasive ductal adenocarcinomas demonstrated strong binding of the ras-p21 antibody. In contrast no obvious differences in expression of c-erbB-2 were evident between the groups. In conclusion, a combined mucin histochemical/immunohistochemical approach may facilitate accurate diagnosis.
 ...
PMID:A mucous histochemical and immunohistochemical study of precancerous and neoplastic lesions in the human pancreas. 810 2

We examined the usefulness of the intraductal ultrasound (IDUS) examinations by comparing the IDUS images with the endoscopic retrograde (ER) pancreatograms. We inserted an IDUS probe with 30 MHz at frequency transpapillary into the main pancreatic duct (MPD) in 105 cases with pancreatic diseases (30 cancers, 30 mucin-producing tumor, 3 islet cell tumor, 1 pancreatic serous cyst adenoma, 1 pancreatic teratoma, 1 pancreatic solid and cystic tumor and 39 chronic pancreatitis). All 105 cases were performed ER pancreatography. Sixty-four of 105 cases (22 cancers, 20 mucin-producing tumor, 3 islet cell tumor, 1 pancreatic serous cyst adenoma, 1 pancreatic teratoma, 1 pancreatic solid and cystic tumor and 16 chronic pancreatitis) were operated and the IDUS images were compared with the corresponding histopathological sections. The usefulness of the IDUS examinations of the pancreatic diseases were the following cases; differential diagnosis between benign and malignant cases with localized stenosis of the MPD, differential diagnosis of the cases with displacement of the MPD, and the diagnosis of the intraductal extent and of invasion of the tumor in the mucin-producing tumor of the pancreas with the dilation of the MPD. IDUS examinations are performed by the IDUS probe with high frequency, so the indications of the IDUS examinations are to detect the small lesions in the pancreas.
 ...
PMID:[Diagnosis of the pancreatic diseases by intraductal ultrasound of the pancreas--with special reference to clinical cases difficult to diagnose differentially pancreatic diseases by the endoscopic retrograde pancreatography]. 813 22

Prospective studies were performed to characterize parotid and parapharyngeal tumours using dynamic magnetic resonance (MR) imaging. Bolus injection of gadopentetate dimeglumine and a short SE sequence were used to evaluate 23 masses including seven pleomorphic adenomas, seven Warthin's tumours and nine malignant tumours. Contrast enhancement profiles helped to distinguish the different types of parotid and parapharyngeal tumours. Gradual increase in intensity during the first 260 s after the injection was characteristically found in pleomorphic adenomas and adenoid cystic carcinomas. Conversely, all Warthin's tumours showed a rapid increase during the first 20 s followed by a decrease in signal intensity. The other malignant tumours showed a rapid increase during the first 20 s followed by gradual decrease or increase at a slow rate. We suggests that the gradual increase in signal intensity of pleomorphic adenoma and adenoid cystic carcinoma may be due to their hypovascularity and an abundance of interstitial regions rich in connective tissue-type mucin. Dynamic MRI shows promise in tissue characterization of parotid and parapharyngeal tumours.
 ...
PMID:Parotid and parapharyngeal tumours: tissue characterization with dynamic magnetic resonance imaging. 817 73

Nineteen patients (10 men, 9 women) with pseudomyxoma peritonei were studied to determine the site of origin of the disease and the nature of associated ovarian tumors. A primary appendiceal mucinous neoplasm was found in 16 of the 17 patients with an evaluable appendix. One woman's appendix had intramural and serosal mucinous deposits without neoplastic epithelial cells. The appendiceal tumors were classified as mucin-producing adenoma ("mucinous cystadenoma") in 13 patients (seven women, six men), intramucosal adenocarcinoma associated with mucin-producing adenoma in one man, and invasive adenocarcinoma associated with mucin-producing adenoma in one man and one woman. Five of the nine women had cystic mucinous ovarian neoplasms; each also had an appendiceal mucinous neoplasm (adenoma in four, invasive adenocarcinoma with adenoma in one). The ovarian neoplasms had histologic features resembling a borderline (low malignant potential) mucinous tumor in four and a mucinous cystadenoma in one; all five ovarian tumors also had features of pseudomyxoma ovarii. Mucinous implants were also on the ovarian surface of the contralateral ovary in four of the five women with ovarian tumors and in the other four women without ovarian tumors. The intraperitoneal mucus deposits contained neoplastic mucinous epithelial cells in 16 patients (eight men, eight women) and were acellular in three (two women, one man). Of 17 patients with more than 6 months of follow-up, 12 (seven women, five men) were alive after postoperative intervals of 7 to 147 months, including three with known residual disease. Five (three men, two women) died of disease 16 to 60 months after initial operation, including two patients with appendiceal carcinoma. Acellular intraperitoneal mucus appeared to be a favorable prognostic feature. We conclude that (a) the appendix is the primary site of origin of pseudomyxoma in the vast majority of cases in both men and women, and (b) the associated mucinous ovarian tumors are most likely secondary neoplasms resulting from incorporation of implanted mucus and neoplastic mucinous epithelial cells of the pseudomyxoma peritonei.
 ...
PMID:Pseudomyxoma peritonei. A clinicopathologic study of 19 cases with emphasis on site of origin and nature of associated ovarian tumors. 817 74


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>